{
  "case_id": "case_0006",
  "provider": "openai",
  "status": "processed",
  "patient_demographics": {
    "age": 40.22,
    "sex": "Female",
    "genderIdentity": "Cisgender Female",
    "ancestry": "South Asian"
  },
  "marking_output": {
    "Localisation": {
      "report_string": "--- Localisation ---\nAgree with lesions involving:\n- right optic nerve (cranial nerve II) and right cerebellum.\n  \nMore precision is possible than: 'left thoracic spinal cord'.  \nNamely: left T4 spinal cord.\n  \nAdditional signs indicate potential further lesion in:\n- right L5 nerve root.",
      "structured_data": {
        "gt_lesions_english": [
          "left T4 myelopathy",
          "right L5 radiculopathy",
          "right optic nerve (cranial nerve II)",
          "right cerebellum"
        ],
        "ft_lesions_parsed": [
          {
            "location": "optic nerve",
            "side": "right",
            "qualifier": null
          },
          {
            "location": "cerebellar hemisphere",
            "side": "right",
            "qualifier": null
          },
          {
            "location": "thoracic spinal cord",
            "side": "left",
            "qualifier": null
          }
        ],
        "exact_matches": [
          "right optic nerve (cranial nerve II)",
          "right cerebellum"
        ],
        "imprecise_matches": [
          [
            "left thoracic spinal cord",
            "left T4 myelopathy"
          ]
        ],
        "missing_lesions_from_ft": [
          "right L5 radiculopathy"
        ],
        "additional_lesions_in_ft": []
      },
      "scoring": {
        "gt_lesion_count": 4,
        "correctly_identified_count": 2,
        "imprecisely_identified_count": 1,
        "missed_lesion_count": 1,
        "additional_lesion_count": 0,
        "proportion_correct": 0.5,
        "proportion_imprecise": 0.25,
        "proportion_missed": 0.25,
        "proportion_additional": 0.0
      }
    },
    "Differential diagnosis": {
      "report_string": "--- Differential diagnosis ---\nCorrectly included Multiple sclerosis.\n\n- Agree with also considering: Autoimmune Myelitis (SLE), CNS Vasculitis, MOG Antibody-Associated Disease, Neuromyelitis Optica Spectrum Disorder (AQP4+), Neurosarcoidosis and Neurosyphilis.\n\nOther considerations not mentioned:\n- Their comorbidity degenerative intervertebral disc disease could account for parts of the examination, e.g. with a lesion affecting right L5 nerve root.\n\nThis suggested differential is less likely to explain the full clinical picture than those above:\n- Spinal cord compression (thoracic)",
      "structured_data": {
        "ft_diagnoses_raw": [
          "Relapsing\u2013remitting multiple sclerosis",
          "Neuromyelitis optica spectrum disorder (AQP4-IgG positive)",
          "MOG antibody-associated disease",
          "Neurosarcoidosis",
          "Systemic autoimmune disease with CNS involvement (e.g., SLE/Sj\u00f6gren\u2019s)",
          "CNS vasculitis",
          "Infectious mimics (HIV, syphilis, Lyme)",
          "Spinal cord compression (thoracic)"
        ],
        "gt_diagnoses_with_source": {
          "Multiple sclerosis": "evaluation",
          "Degenerative intervertebral disc disease": "comorbidity"
        },
        "correctly_mentioned_original_gt": [
          "Multiple sclerosis"
        ],
        "missing_original_gt": [
          "Degenerative intervertebral disc disease"
        ],
        "matched_lesion_dx_keys": [
          "Neurosarcoidosis",
          "Syphilis",
          "AQP4_NMOSD",
          "CNS_Vasculitis",
          "MS",
          "MOGAD",
          "Autoimmune_Myelitis_SLE"
        ],
        "missing_lesion_dx_keys": [],
        "additional_diagnoses": [
          "Spinal cord compression (thoracic)"
        ]
      },
      "scoring": {
        "primary_diagnosis_included": 1,
        "primary_diagnosis_name": "Multiple sclerosis",
        "gt_total_count": 2,
        "gt_matched_count": 1,
        "gt_missed_count": 1,
        "gt_coverage_percentage": 0.5,
        "additional_inappropriate_count": 1,
        "comorbidity_total_count": 1,
        "comorbidity_missing_count": 1,
        "comorbidity_missing_proportion": 1.0
      }
    },
    "Investigations": {
      "report_string": "--- Investigations ---\n\n- Agree with the suggested MRI including the Lumbosacral Spine - would potentially inform a diagnosis/details of degenerative intervertebral disc disease.\n\n- Agree with the suggested MRI including the Orbits; Thoracic Spine, and Brain and CSF test for Oligoclonal Bands - would potentially inform a diagnosis/details of multiple sclerosis.\n\nTo evaluate other differential diagnoses:\n- Agree with considering: ANA, serum AQP4 Ab, ENA, serum MOG Ab, serum ACE, syphilis.\n- Could also consider: serum ANCA.",
      "structured_data": {
        "gt_required_tests_primary": [
          {
            "type": "CSF",
            "detail": "Oligoclonal Bands",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Lumbosacral Spine",
            "condition": "Degenerative intervertebral disc disease"
          },
          {
            "type": "MRI",
            "region": "Orbits",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Thoracic Spine",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Brain",
            "condition": "Multiple sclerosis"
          }
        ],
        "ft_proposed_investigations": [
          "MRI brain, orbits and whole spine with gadolinium",
          "Lumbar puncture for CSF analysis including cell count, protein, glucose, oligoclonal bands and IgG index",
          "Visual evoked potentials",
          "Optical coherence tomography",
          "Full blood count",
          "Urea and electrolytes",
          "Liver function tests",
          "C-reactive protein",
          "Erythrocyte sedimentation rate",
          "Thyroid function tests",
          "Vitamin B12",
          "Serum folate",
          "Serum copper and ceruloplasmin",
          "Antinuclear antibody",
          "Extractable nuclear antigen panel (including anti-SSA/SSB)",
          "Double-stranded DNA antibody",
          "Serum ACE",
          "Aquaporin-4 IgG (cell-based assay)",
          "MOG-IgG (cell-based assay)",
          "HIV antigen/antibody",
          "Syphilis serology (RPR/TPPA)",
          "Lyme disease serology",
          "Hepatitis B surface antigen and core antibody",
          "Hepatitis C antibody",
          "Quantiferon-TB Gold",
          "JC virus antibody index",
          "25-hydroxy vitamin D",
          "Serum pregnancy test (if applicable)"
        ],
        "found_tests_primary": [
          {
            "type": "MRI",
            "region": "Lumbosacral Spine",
            "condition": "Degenerative intervertebral disc disease"
          },
          {
            "type": "MRI",
            "region": "Orbits",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Thoracic Spine",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Brain",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "CSF",
            "detail": "Oligoclonal Bands",
            "condition": "Multiple sclerosis"
          }
        ],
        "missing_tests_primary": [],
        "expected_inv_keys_ddx": [
          "ANA",
          "ANCA",
          "AQP4_Antibodies",
          "ENA_Panel",
          "MOG_Antibodies",
          "Serum_ACE",
          "Syphilis_Serology"
        ],
        "found_inv_keys_ddx": [
          "MOG_Antibodies",
          "AQP4_Antibodies",
          "Syphilis_Serology",
          "ENA_Panel",
          "Serum_ACE",
          "ANA"
        ],
        "missing_inv_keys_ddx": [
          "ANCA"
        ]
      },
      "scoring": {
        "primary_tests_required_count": 5,
        "primary_tests_found_count": 5,
        "primary_tests_missed_count": 0,
        "primary_tests_coverage_percentage": 1.0,
        "ddx_tests_expected_count": 7,
        "ddx_tests_found_count": 6,
        "ddx_tests_coverage_percentage": 0.8571428571428571
      }
    },
    "Management": {
      "report_string": "--- Management ---\nSteroids: Not appropriate to start treatment immediately.\n  \nAdditional factors not mentioned:\n\n- Evidence of potential active intercurrent infection (CXR: perihilar Ground-glass changes.).\n\n- Presenting complaint not specified, so no indication whether this is a new or an old deficit.\n\nDMTs: Appropriate to consider but delay treatment.\n  \nCorrectly identified the following:\n\n- Need confirmation of MS diagnosis.\n  \nAdditional factors not mentioned:\n\n- Evidence of potential active intercurrent infection (CXR: perihilar Ground-glass changes.).\n\n- Need a pregnancy test result.",
      "structured_data": {
        "ft_full_plan_parsed": [
          {
            "treatment": "Intravenous methylprednisolone 1 g daily for 3\u20135 days (or oral equivalent 500\u20131250 mg)",
            "timing": "Start Now",
            "reasons": [
              "Acute disabling relapse with optic/cerebellar signs",
              "Improves speed of recovery",
              "Vitals stable and no sepsis features; infection screen to proceed in parallel"
            ]
          },
          {
            "treatment": "Proton pump inhibitor while on high-dose steroids",
            "timing": "Start Now",
            "reasons": [
              "GI protection during pulse steroids",
              "Reduces risk of steroid-induced gastritis/ulcer"
            ]
          },
          {
            "treatment": "Physiotherapy and occupational therapy",
            "timing": "Start Now",
            "reasons": [
              "Gait ataxia and left-leg spasticity causing functional impairment",
              "Prevents deconditioning and falls"
            ]
          },
          {
            "treatment": "Baclofen for spasticity (titrate)",
            "timing": "Start Now",
            "reasons": [
              "Objective left lower-limb spasticity with clonus",
              "Improves mobility and comfort"
            ]
          },
          {
            "treatment": "Plasma exchange (5\u20137 exchanges) if steroid-refractory",
            "timing": "Delay",
            "reasons": [
              "Second-line for severe relapse not improving within 2 weeks",
              "More invasive therapy reserved for nonresponse"
            ]
          },
          {
            "treatment": "Initiate high-efficacy disease-modifying therapy (e.g., ocrelizumab or natalizumab depending on JCV status)",
            "timing": "Delay",
            "reasons": [
              "Start after diagnostic confirmation and baseline screening",
              "Vaccination optimisation and risk stratification required"
            ]
          },
          {
            "treatment": "Vaccination updates (VZV, influenza, COVID-19, HBV as indicated)",
            "timing": "Delay",
            "reasons": [
              "Reduce infection risk before immunotherapy",
              "Live vaccines contraindicated after immunosuppression"
            ]
          },
          {
            "treatment": "Vitamin D supplementation (e.g., cholecalciferol 1000\u20132000 IU daily)",
            "timing": "Start Now",
            "reasons": [
              "Low vitamin D is associated with MS activity",
              "Safe and may reduce relapse risk"
            ]
          }
        ],
        "steroids_evaluation": {
          "ft_plan": {
            "treatment": "Intravenous methylprednisolone 1 g daily for 3\u20135 days (or oral equivalent 500\u20131250 mg)",
            "timing": "Start Now",
            "reasons": [
              "Acute disabling relapse with optic/cerebellar signs",
              "Improves speed of recovery",
              "Vitals stable and no sepsis features; infection screen to proceed in parallel"
            ]
          },
          "gt_plan": {
            "treatment_inappropriate": true,
            "reasons": {
              "missing_information": [
                "Presenting complaint not specified, so no indication whether this is a new or an old deficit."
              ],
              "contraindications": [
                "Evidence of potential active intercurrent infection (CXR: perihilar Ground-glass changes.)."
              ]
            }
          },
          "evaluation_summary": "Not appropriate to start treatment immediately.\n  \nAdditional factors not mentioned:\n\n- Evidence of potential active intercurrent infection (CXR: perihilar Ground-glass changes.).\n\n- Presenting complaint not specified, so no indication whether this is a new or an old deficit."
        },
        "dmt_evaluation": {
          "ft_plan": {
            "treatment": "Initiate high-efficacy disease-modifying therapy (e.g., ocrelizumab or natalizumab depending on JCV status)",
            "timing": "Delay",
            "reasons": [
              "Start after diagnostic confirmation and baseline screening",
              "Vaccination optimisation and risk stratification required"
            ]
          },
          "gt_plan": {
            "treatment_inappropriate": true,
            "reasons": {
              "missing_information": [
                "Need confirmation of MS diagnosis.",
                "Need a pregnancy test result."
              ],
              "contraindications": [
                "Evidence of potential active intercurrent infection (CXR: perihilar Ground-glass changes.)."
              ]
            }
          },
          "evaluation_summary": "Appropriate to consider but delay treatment.\n  \nCorrectly identified the following:\n\n- Need confirmation of MS diagnosis.\n  \nAdditional factors not mentioned:\n\n- Evidence of potential active intercurrent infection (CXR: perihilar Ground-glass changes.).\n\n- Need a pregnancy test result."
        }
      },
      "scoring": {
        "steroids": {
          "decision_category": "inappropriate_commission",
          "is_unsafe": 1,
          "reasons_total": 2,
          "reasons_acknowledged": 0,
          "reasons_missed": 2,
          "reasons_coverage_percentage": 0.0
        },
        "dmt": {
          "decision_category": "appropriate_caution",
          "is_unsafe": 0,
          "reasons_total": 3,
          "reasons_acknowledged": 1,
          "reasons_missed": 2,
          "reasons_coverage_percentage": 0.3333333333333333
        }
      }
    }
  }
}